2011
DOI: 10.1186/1824-7288-37-6
|View full text |Cite
|
Sign up to set email alerts
|

Breastfeeding and transmission of cytomegalovirus to preterm infants. Case report and kinetic of CMV-DNA in breast milk

Abstract: BackgroundBreastfeeding has a major impact on CMV epidemiology. Postnatal CMV reactivation's incidence during lactation is nearby the maternal seroprevalence. Although perinatal CMV infection has practically no consequences in term newborn, it may cause, in some cases, a severe symptomatic disease in preterm newborns.The aims of the present study are to evaluate the rate and clinical expression of CMV infection breast milk transmitted in preterm infants and to check the safety of the freezing treated breast mi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
40
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(44 citation statements)
references
References 19 publications
3
40
0
1
Order By: Relevance
“…Infectious virus and CMV DNA and RNA have been isolated from cellassociated and whey fractions in the breast milk of 40% to 97% of CMVseropositive lactating women. [7][8][9][10][11][12][13][14][15][16][17] In the United States, an estimated 58% of pregnancies occur among CMVseropositive women. 19 Because few data exist on the incidence of breast milk-acquired CMV infection and disease among premature infants, we conducted a systematic review and meta-analysis of studies reporting on postnatal CMV infection and disease presumably acquired via consumption of breast milk among very low birth weight (VLBW) and premature infants born to CMV-seropositive women but uninfected at birth.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Infectious virus and CMV DNA and RNA have been isolated from cellassociated and whey fractions in the breast milk of 40% to 97% of CMVseropositive lactating women. [7][8][9][10][11][12][13][14][15][16][17] In the United States, an estimated 58% of pregnancies occur among CMVseropositive women. 19 Because few data exist on the incidence of breast milk-acquired CMV infection and disease among premature infants, we conducted a systematic review and meta-analysis of studies reporting on postnatal CMV infection and disease presumably acquired via consumption of breast milk among very low birth weight (VLBW) and premature infants born to CMV-seropositive women but uninfected at birth.…”
Section: Resultsmentioning
confidence: 99%
“…The 17 studies included in this review were published from 2001 to 2011 (Table 1). [8][9][10][11][12][13][14][15][16][17][25][26][27][28][29][30][31] Nine studies were conducted in Europe (Germany, Italy, France, United Kingdom, and Sweden), 4 in Asia (Japan and Taiwan), 2 in North America (Canada and United States), 1 in South America (Brazil), and 1 in the Middle East (Israel).…”
Section: Systematic Reviewmentioning
confidence: 99%
“…Other studies re ported a CMV transmission rate of 2.5% to 15% when FT BM is used [29][30][31] . While HP is highly effective at removing viable CMV, it may inactivate biologically active components such as Igs, enzymes, hormones, growth factors, cytokines, and heat-labile vitamins 6,32) .…”
Section: Resultsmentioning
confidence: 99%
“…Los factores de riesgo relacionados con la transmisión son la magnitud de la carga viral, la excreción viral precoz en la leche, la duración de la lactancia y los métodos de preservación de la leche. 2,5,[10][11][12] E l c i t o m e g a l o v i r u s e s u n v i r u s l á b i l que puede ser eliminado por altas o bajas temperaturas. La congelación a -12 º C reduce el riesgo de transmisión, pero no lo elimina por completo.…”
Section: -8unclassified